SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: ubernano, TomP1
Search This Board:
Last Post: 1/12/2017 12:44:29 PM - Followers: 407 - Board type: Free - Posts Today: 0

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#13518  Sticky Note 2016 VALUE DRIVERS & MILESTONES (2nd-Half of 2016 Dr_Thorfin 08/01/16 01:50:30 PM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13771   The Inovio story is devolving into comedy. I ubernano 01/12/17 12:44:29 PM
#13770   INO So now the hope here is effectiveness MiamiGent 01/12/17 10:16:20 AM
#13769   More Innovation, Less Regulation: 2 Biotech Stocks That ubernano 01/11/17 01:06:30 PM
#13768   Great post! Buy under 5 Fibanotch 01/10/17 09:32:26 AM
#13767   Thanks MG! ubernano 12/28/16 10:01:39 AM
#13766   A great company? It hasn't produced anything during MiamiGent 12/27/16 07:58:00 PM
#13765   This news brings $20+ as we approach mosquito biotechnician 12/27/16 01:41:11 PM
#13761   Iovio is a great company and as a ubernano 12/26/16 01:10:39 PM
#13760   Approval is not a given but they are INTL 12/26/16 11:27:39 AM
#13759   MedImmune? AstraZeneca? DARPA? Department of Defense? TomP1 12/26/16 04:51:25 AM
#13758   Sorry where do you see the victory claim??? TomP1 12/26/16 04:50:32 AM
#13757   INO Essential Inovio- all you need to know.. MiamiGent 12/25/16 11:42:46 PM
#13756   Nothing to do with Inovio. MiamiGent 12/25/16 11:10:35 PM
#13755   And Inovio has nothing to do with Merck MiamiGent 12/25/16 11:04:46 PM
#13754   No, junk stock from a crooked company in MiamiGent 12/25/16 10:54:58 PM
#13753   INO Yet more pumping from Inovio- one of MiamiGent 12/25/16 10:51:22 PM
#13751   Inovio is using disproved technology, discarded by other MiamiGent 12/25/16 10:31:27 PM
#13750   False. Inovio is no where near final approval MiamiGent 12/25/16 10:27:18 PM
#13749   INO More farm work. Under direction from another MiamiGent 12/25/16 10:21:41 PM
#13748   New Ebola Vaccine Offers Up To 100 Percent ubernano 12/24/16 09:35:42 AM
#13747   MRK vaccine effective for 1 strain of Ebola: north40000 12/24/16 07:29:29 AM
#13746   Effective for this one string of Ebola and TomP1 12/23/16 08:32:43 AM
#13745   Oh,oh. MRK has "highly effective" Ebola vaccine. Today's treboriluap 12/23/16 08:15:28 AM
#13744   INO dip over and going high now, looks knrorrel 12/21/16 10:51:13 AM
#13743   i hope soon break $8 and FLYING TO 10 knrorrel 12/21/16 10:16:12 AM
#13742   Nice news! fireopal 12/21/16 09:45:56 AM
#13741   SOUND VERY GOOD knrorrel 12/21/16 09:07:03 AM
#13740   GLS-5700 hits a home run! ubernano 12/21/16 09:02:25 AM
#13739 knrorrel 12/21/16 08:55:51 AM
#13738   LOOKS VERY GOOD ON STRONG NEWS knrorrel 12/21/16 08:54:14 AM
#13736   INO strong news just out knrorrel 12/21/16 08:50:18 AM
#13735   Orders of magnitude better than $7. ubernano 12/19/16 01:39:03 PM
#13734   How is this s 7 dollar stock unreal Dynarod 12/19/16 09:35:32 AM
#13733   Final step in approval process. Labeling and shelf INTL 12/19/16 07:48:14 AM
#13732   * * $INOV Video Chart 12-13-16 * * ClayTrader 12/13/16 05:12:47 PM
#13731 INTL 12/09/16 07:25:55 PM
#13730   Volume up AH. INTL 12/09/16 07:17:04 PM
#13729   Inovio MERS Vaccine Development to be Expanded with ubernano 12/06/16 08:45:04 AM
#13728   Gates gives Wistar $9 million for novel fight ubernano 12/03/16 12:47:11 PM
#13727   Inovio Pharmaceuticals' Next Zika Opportunity ubernano 12/01/16 07:30:58 PM
#13725   Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar ubernano 12/01/16 09:40:30 AM
#13724   Inovio’s Co-Founder and Chair of its Scientific Advisory ubernano 11/21/16 08:29:18 AM
#13723   What these anti INO comments lack in content ubernano 11/16/16 10:23:28 AM
#13722   MG, your link doesn't lead anywhere, much like ubernano 11/16/16 10:01:02 AM
#13721   have told you that i have made money fireopal 11/16/16 09:02:35 AM
#13720   Inovio Wins Deloitte’s “Fast 500” Growth Award Developer TomP1 11/16/16 08:31:40 AM
#13719   MiamiGent Member Level Monday, 08/05/13 08:23:15 AM MiamiGent 11/16/16 01:15:30 AM
#13718   MiamiGent Member Level Wednesday, 08/07/13 12:29:35 AM MiamiGent 11/16/16 01:13:45 AM
#13717   INO Might be helpful to new viewers to MiamiGent 11/16/16 12:55:16 AM
#13716   I hear you not refuting my assertion. That's boring. MiamiGent 11/16/16 12:40:55 AM